“parkinsons-disease” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders 09/23/20 San Diego
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests 08/27/20 Seattle
Yumanity to Merge With Proteostasis to Advance Neuro Drug Pipeline 08/24/20 Boston
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
AbbVie Walks From Voyager R&D Pact Spanning Alzheimer’s, Parkinson’s 08/04/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Acadia Halts Work on Depression Drug After Late-Stage Trial Failure 07/21/20 San Diego
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs 04/29/20 National
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill 04/27/20 San Diego
Cerevance Raises $45M to Advance Brain Disease Research & Development 04/14/20 Boston
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic 04/01/20 San Diego
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies 02/28/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise 02/19/20 Boston
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins 01/29/20 New York
Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer 01/13/20 Boston
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Page 1 of 6 next page »